Yu JH - Search Results

1

How does hepatic steatosis affect the outcome of patients with chronic hepatitis B?

Yu JH, Lee JW. Yu JH, et al. Clin Mol Hepatol. 2019 Sep;25(3):280-282. doi: 10.3350/cmh.2018.0104. Epub 2019 Jan 21. Clin Mol Hepatol. 2019. PMID: 30661335 Free PMC article. No abstract available.

2

Platelet-derived growth factor receptor α in hepatocellular carcinoma is a prognostic marker independent of underlying liver cirrhosis.

Yu JH, Kim JM, Kim JK, Choi SJ, Lee KS, Lee JW, Chang HY, Lee JI. Yu JH, et al. Oncotarget. 2017 Jun 13;8(24):39534-39546. doi: 10.18632/oncotarget.17134. Oncotarget. 2017. PMID: 28465473 Free PMC article.

3

Antiviral Therapy in Patients With Chronic Hepatitis C-related Hepatocellular Carcinoma Responding to Palliative Treatment.

Yu JH, Kim JK, Lee KS, Lee JI. Yu JH, et al. J Clin Gastroenterol. 2018 Jul;52(6):557-562. doi: 10.1097/MCG.0000000000000923. J Clin Gastroenterol. 2018. PMID: 28863014

4

Remaining hepatocellular carcinoma risk in chronic hepatitis B patients receiving entecavir/tenofovir in South Korea.

Yu JH, Jin YJ, Lee JW, Lee DH. Yu JH, et al. Hepatol Res. 2018 Oct;48(11):862-871. doi: 10.1111/hepr.13194. Epub 2018 Jun 4. Hepatol Res. 2018. PMID: 29761604

5

Prediction model for hepatocellular carcinoma risk in treatment-naive chronic hepatitis B patients receiving entecavir/tenofovir.

Yu JH, Suh YJ, Jin YJ, Heo NY, Jang JW, You CR, An HY, Lee JW. Yu JH, et al. Eur J Gastroenterol Hepatol. 2019 Jul;31(7):865-872. doi: 10.1097/MEG.0000000000001357. Eur J Gastroenterol Hepatol. 2019. PMID: 30694912

6

Effective therapeutic options for elderly patients with hepatocellular carcinoma: A nationwide cohort study.

Shin J, Yu JH, Jin YJ, Suh YJ, Kim DH, Byun S, Lee JW. Shin J, et al. Among authors: yu jh. Medicine (Baltimore). 2019 Jul;98(30):e16150. doi: 10.1097/MD.0000000000016150. Medicine (Baltimore). 2019. PMID: 31348228 Free PMC article.

7

Comparison of survival outcomes of alcohol-related hepatocellular carcinoma with or without liver cirrhosis; a ten-year experience.

Shin J, Yu JH, Jin YJ, Chae MH, Yoon CH, Lee JW. Shin J, et al. Among authors: yu jh. Medicine (Baltimore). 2019 Nov;98(47):e18020. doi: 10.1097/MD.0000000000018020. Medicine (Baltimore). 2019. PMID: 31764818 Free PMC article.

8

Limited expression of toll-like receptor 9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease.

Yu JH. Yu JH. Clin Mol Hepatol. 2020 Apr;26(2):240-241. doi: 10.3350/cmh.2020.0048. Epub 2020 Mar 23. Clin Mol Hepatol. 2020. PMID: 32192316 Free PMC article. No abstract available.

9

Predictive score for hepatocellular carcinoma after hepatitis B e antigen loss in patients treated with entecavir or tenofovir.

Lim TS, Lee HW, Lee JI, Kim IH, Lee CH, Jang BK, Chung WJ, Yim HJ, Suh SJ, Seo YS, Lee HA, Yu JH, Lee JW, Kim SG, Kim YS, Park SY, Tak WY, Kim SS, Cheong JY, Jeong SW, Jang JY, Rou WS, Lee BS, Kim SU; Korean Transient Elastography Study Group. Lim TS, et al. Among authors: yu jh. J Viral Hepat. 2020 Oct;27(10):1052-1060. doi: 10.1111/jvh.13316. Epub 2020 May 28. J Viral Hepat. 2020. PMID: 32383246

10

Survival Outcomes According to Body Mass Index in Hepatocellular Carcinoma Patient: Analysis of Nationwide Cancer Registry Database.

Cha B, Yu JH, Jin YJ, Suh YJ, Lee JW. Cha B, et al. Among authors: yu jh. Sci Rep. 2020 May 20;10(1):8347. doi: 10.1038/s41598-020-65460-9. Sci Rep. 2020. PMID: 32433488 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,565 results

Search Page

Filters